Cargando…
Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
[Image: see text] The modulation of the A(2B) adenosine receptor is a promising strategy in cancer (immuno) therapy, with A(2B)AR antagonists emerging as immune checkpoint inhibitors. Herein, we report a systematic assessment of the impact of (di- and mono-)halogenation at positions 7 and/or 8 on bo...
Autores principales: | Prieto-Díaz, Rubén, González-Gómez, Manuel, Fojo-Carballo, Hugo, Azuaje, Jhonny, El Maatougui, Abdelaziz, Majellaro, Maria, Loza, María I., Brea, José, Fernández-Dueñas, Víctor, Paleo, M. Rita, Díaz-Holguín, Alejandro, Garcia-Pinel, Beatriz, Mallo-Abreu, Ana, Estévez, Juan C., Andújar-Arias, Antonio, García-Mera, Xerardo, Gomez-Tourino, Iria, Ciruela, Francisco, Salas, Cristian O., Gutiérrez-de-Terán, Hugo, Sotelo, Eddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841532/ https://www.ncbi.nlm.nih.gov/pubmed/36517209 http://dx.doi.org/10.1021/acs.jmedchem.2c01768 |
Ejemplares similares
-
Exploring Non-orthosteric Interactions with a Series
of Potent and Selective A(3) Antagonists
por: Miranda-Pastoriza, Darío, et al.
Publicado: (2022) -
Optimization of
2-Amino-4,6-diarylpyrimidine-5-carbonitriles
as Potent and Selective A(1) Antagonists
por: Val, Cristina, et al.
Publicado: (2022) -
Potent and Subtype-Selective
Dopamine D(2) Receptor Biased Partial Agonists Discovered
via an Ugi-Based Approach
por: Mallo-Abreu, Ana, et al.
Publicado: (2021) -
A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022) -
X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A(2A) Adenosine Receptor Antagonists
por: Jespers, Willem, et al.
Publicado: (2020)